SABCS 2016: The Search for an Effective and Safe PI3K-Inhibitor
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Tag: Breast cancer
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...
A study presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium found that women who received breast...
Genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies revealed multiple alterations...
SABCS is a comprehensive scientific meeting that provides the latest information on prevention, diagnosis, and treatment of breast cancer...
Sasha Stanton, MD, PhD, is a breast cancer physician-scientist dedicated to developing a DCIS vaccine.
This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However,...
As the temperature soared this summer, the laps around the park became harder to endure. When her skin chafed...
Josette Northcott, PhD, is exploring the role that blood vessels play in the growth of tumors and the delivery...
Guest Post by Virginia Kaklamani, MD, DSc Co-director of the San Antonio Breast Cancer Symposium (SABCS)